rxstat › Drug prices › Amantadine

Amantadine price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Amantadine 10 mg/ml syrup costs about $0.090 to $0.11 per mL on public drug plan price lists across 9 provinces, before the pharmacy's dispensing fee.

Amantadine has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formBCABSKMBONNBNSPENL
10 mg/ml Syrupper mL$0.11$0.099$0.099$0.099$0.099$0.099$0.099$0.099$0.090
50 mg/5ml Syrupper mL$0.11$0.099$0.099$0.099$0.099$0.099$0.099$0.099$0.11
100 mg Capsuleper capsule$0.84$0.63$0.76–$0.57$0.55$0.74–$0.79
Plan coverageCoveredCoveredCoveredPrice listCoveredCoveredCoveredPrice listPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

British Columbia: 3 products
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PMS
    DIN 02022826 · $0.11/mL · Covered
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.11/mL · Covered
  • Pdp-Amantadine Hydrochloride Capsules 100 mg Capsule · PDP
    DIN 01990403 · $0.84/capsule · Covered
Alberta: 3 products
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.099/mL · Covered
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PPH
    DIN 02022826 · $0.099/mL · Covered
  • Pdp-Amantadine Hydrochloride Capsules 100 mg Capsule · PPH
    DIN 01990403 · $0.63/capsule · Covered
Saskatchewan: 3 products
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PED
    DIN 02022826 · $0.099/mL · Covered
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.099/mL · Covered
  • Pdp-Amantadine Hydrochloride Capsules 100 mg Capsule · PED
    DIN 01990403 · $0.76/capsule · Covered
Manitoba: 2 products
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.099/mL · Price list
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PPI
    DIN 02022826 · $0.099/mL · Price list
Ontario: 5 products
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · Pendopharm, Division of Pharmascience Inc.
    DIN 02022826 · $0.099/mL · Covered
  • Odan-Amantadine Syrup 10 mg/ml Syrup · Odan Laboratories Ltd.
    DIN 02538601 · $0.099/mL · Covered
  • Pdp-Amantadine Hydrochloride Capsules 100 mg Capsule · Pendopharm, Division of Pharmascience Inc.
    DIN 01990403 · $0.57/capsule · Covered
  • Symmetrel Capsules 100mg 100 mg Capsule · Bristol Myers Squibb Canada Inc
    DIN 01914006 · no listed price · Not covered
  • Symmetrel Syrup 10mg/Ml 10 mg/ml Syrup · Bristol Myers Squibb Canada Inc
    DIN 01913999 · no listed price · Not covered
New Brunswick: 3 products
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PDP
    DIN 02022826 · $0.099/mL · Covered
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.099/mL · Covered
  • Pdp-Amantadine Hydrochloride Capsules 100 mg Capsule · PDP
    DIN 01990403 · $0.55/capsule · Covered
Nova Scotia: 6 products
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PDP
    DIN 02022826 · $0.099/mL · Covered
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.099/mL · Covered
  • Pdp-Amantadine Hydrochloride Capsules 100 mg Capsule · PDP
    DIN 01990403 · $0.74/capsule · Covered
  • Symmetrel Capsules 100mg 100 mg Capsule · BRI
    DIN 01914006 · no listed price · Not covered
  • Endantadine 100 mg Capsule · BRI
    DIN 02034468 · no listed price · Not covered
  • Symmetrel Syrup 10mg/Ml 10 mg/ml Syrup · BRI
    DIN 01913999 · no listed price · Not covered
Prince Edward Island: 2 products
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PDP
    DIN 02022826 · $0.099/mL · Price list
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.099/mL · Price list
Newfoundland and Labrador: 5 products
  • Symmetrel Syrup 10mg/Ml 10 mg/ml Syrup · BRI
    DIN 01913999 · $0.090/mL · Price list
  • Odan-Amantadine Syrup 10 mg/ml Syrup · ODN
    DIN 02538601 · $0.11/mL · Price list
  • Pdp-Amantadine Hydrochloride Syrup 50 mg/5ml Syrup · PEN
    DIN 02022826 · $0.11/mL · Price list
  • Pdp-Amantadine Hydrochloride Capsules 100 mg Capsule · PMS
    DIN 01990403 · $0.79/capsule · Price list
  • Symmetrel Capsules 100mg 100 mg Capsule · BRI
    DIN 01914006 · $1.23/capsule · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · BC PharmaCare Low Cost Alternative list (Nov 5, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · PEI Pharmacare Maximum Reimbursable Price List (Nov 24, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026) · Manitoba Drug Interchangeability Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 2
Reports on file
3

Reports by product

The DIN is printed on your prescription label.

Resolved
PDP-AMANTADINE HYDROCHLORIDE SYRUP
10MG · SYRUP · PENDOPHARM DIVISION OF PHARMASCIENCE INC
DIN 02022826 · ended Jan 7, 2019 · Demand increase for the drug.
Resolved
PMS-AMANTADINE HYDROCHLORIDE CAP 100MG
100MG · CAPSULES · PHARMASCIENCE INC
DIN 01990403 · ended Feb 9, 2018 · Disruption of the manufacture of the drug.
Resolved
PDP-AMANTADINE HYDROCHLORIDE SYRUP
10MG · SYRUP · PENDOPHARM DIVISION OF DE PHARMASCIENCE INC
DIN 02022826 · ended May 24, 2017 · Demand increase for the drug.

What's happening

There are no active shortage reports for Amantadine. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Amantadine is classified under “DOPAMINERGIC AGENTS” (ATC N04BB01).

Recent changes

Common questions

How much does Amantadine cost in Canada?

Amantadine 10 mg/ml syrup costs about $0.090 to $0.11 per mL on public drug plan price lists across 9 provinces, before the pharmacy's dispensing fee.

Is Amantadine covered by provincial drug plans?

On the public plans' own lists: British Columbia: covered; Alberta: covered; Saskatchewan: covered; Manitoba: price list; Ontario: covered; New Brunswick: covered; Nova Scotia: covered; Prince Edward Island: price list; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Amantadine be back in stock in Canada?

Amantadine has no active shortage; supply is normal per Health Canada reports.

Why is Amantadine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (dopaminergic agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.